<?xml version="1.0" encoding="UTF-8"?>
<p id="p0035">The results of a recent meta-analysis of nine studies showed that the IL-6 levels were significantly increased in COVID-19-infected patients with severe conditions (SMD = 0.71, 95%CI –0.31 to 1.12, 
 <italic>p</italic> = 0.0005) (
 <xref rid="bib25" ref-type="bibr">25</xref>). Ruan and colleagues showed the elevated level of IL-6 in critically ill individuals with COVID-19 (
 <xref rid="bib26" ref-type="bibr">26</xref>). Similarly, other reports also established the increased level of IL-6 in patients with confirmed COVID-19 pneumonia and it has been shown that the level of IL-6 has a positive correlation with the severity of the disease (
 <xref rid="bib4" ref-type="bibr">4</xref>,
 <xref rid="bib27" ref-type="bibr">27</xref>,
 <xref rid="bib28" ref-type="bibr">28</xref>).
</p>
